29/09/2026
⚠️ Important Update: Changes to Insulin Availability in Aotearoa NZ.
There are changes happening to the availability of several insulin products in New Zealand, with multiple products being discontinued by the end of 2026.
These include:
🔹 PenMix 30 & Mixtard 30 – already phased out
🔹 3 mL vials of Actrapid & Protaphane
🔹 NovoMix 30 prefilled pens
🔹 10 mL vials of Humalog, Apidra, Humulin R, Humulin NPH & Humulin 30/70
These changes may particularly affect people who use syringes, insulin pumps, or require insulin in inpatient settings.
✅ Importantly, there is no change to the availability of other insulin products at this stage.
What should you do?
If you or someone you support uses one of the affected insulin products, don't wait until the last minute.
👉 Speak with your GP, diabetes specialist, pharmacist or diabetes team about whether you will need to change insulin and what the appropriate alternative is.
👉 Identify people who may be affected and make changes early — ideally before Christmas.
Please do not change or stop your insulin without discussing it with your healthcare professional.
📌 For the most up-to-date information, check Pharmac NZ and your healthcare provider, as insulin supply information can change.